AI-Driven Deep Learning Model for Predicting Immunotherapy Maintenance Benefit in Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Precision Oncology Study
This multicenter study developed and validated an AI-driven deep learning model using automated CT segmentation and clinical data to effectively predict which patients with advanced esophageal squamous cell carcinoma will derive significant survival benefits from immunotherapy maintenance, thereby enabling precision treatment optimization.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.